These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A Novel Subset of CD95 Johnson C; Drummer Iv C; Shan H; Shao Y; Sun Y; Lu Y; Saaoud F; Xu K; Nanayakkara G; Fang P; Bagi Z; Jiang X; Choi ET; Wang H; Yang X Front Immunol; 2020; 11():619951. PubMed ID: 33488632 [TBL] [Abstract][Full Text] [Related]
6. Differences in metabolic characteristics between Metabolically Healthy Obesity (MHO) and Metabolically Unhealthy Obesity (MUO) in weight reduction therapy. Kawai S; Yamakage H; Kotani K; Noda M; Satoh-Asahara N; Hashimoto K Endocr J; 2023 Dec; 70(12):1175-1186. PubMed ID: 37793817 [TBL] [Abstract][Full Text] [Related]
8. Metabolic phenotyping in people living with obesity: Implications for dietary prevention. Blaak EE; Goossens GH Rev Endocr Metab Disord; 2023 Oct; 24(5):825-838. PubMed ID: 37581871 [TBL] [Abstract][Full Text] [Related]
9. Pathogenesis, Murine Models, and Clinical Implications of Metabolically Healthy Obesity. Cho YK; Lee Y; Jung CH Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077011 [TBL] [Abstract][Full Text] [Related]
10. Which predictors differentiate between obese children and adolescents with cardiometabolic complications and those with metabolically healthy obesity? Margolis-Gil M; Yackobovitz-Gavan M; Phillip M; Shalitin S Pediatr Diabetes; 2018 Nov; 19(7):1147-1155. PubMed ID: 29802767 [TBL] [Abstract][Full Text] [Related]
11. Interaction of Metabolic Health and Obesity on Subclinical Target Organ Damage. Lee HJ; Kim HL; Chung J; Lim WH; Seo JB; Kim SH; Zo JH; Kim MA Metab Syndr Relat Disord; 2018 Feb; 16(1):46-53. PubMed ID: 29319402 [TBL] [Abstract][Full Text] [Related]
12. Are There Differences in Hair Mineral Concentrations Between Metabolically Healthy and Unhealthy Obese Adults? Lee YA; Kim SH; Kim HN; Song SW Biol Trace Elem Res; 2020 Feb; 193(2):311-318. PubMed ID: 30972534 [TBL] [Abstract][Full Text] [Related]
13. Exploring Therapeutic Targets to Reverse or Prevent the Transition from Metabolically Healthy to Unhealthy Obesity. Dagpo TD; Nolan CJ; Delghingaro-Augusto V Cells; 2020 Jul; 9(7):. PubMed ID: 32630256 [TBL] [Abstract][Full Text] [Related]
14. Mediterranean diet and mortality risk in metabolically healthy obese and metabolically unhealthy obese phenotypes. Park YM; Steck SE; Fung TT; Zhang J; Hazlett LJ; Han K; Merchant AT Int J Obes (Lond); 2016 Oct; 40(10):1541-1549. PubMed ID: 27339604 [TBL] [Abstract][Full Text] [Related]
15. Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular Risk. Mongraw-Chaffin M; Foster MC; Anderson CAM; Burke GL; Haq N; Kalyani RR; Ouyang P; Sibley CT; Tracy R; Woodward M; Vaidya D J Am Coll Cardiol; 2018 May; 71(17):1857-1865. PubMed ID: 29699611 [TBL] [Abstract][Full Text] [Related]
16. Metabolically healthy obesity, vitamin D, and all-cause and cardiometabolic mortality risk in NHANES III. Al-Khalidi B; Kimball SM; Kuk JL; Ardern CI Clin Nutr; 2019 Apr; 38(2):820-828. PubMed ID: 29525513 [TBL] [Abstract][Full Text] [Related]
18. Metabolic inflexibility in youth with obesity: Is it a feature of obesity or distinctive of youth who are metabolically unhealthy? Gebara NY; Kim JY; Bacha F; Lee S; Arslanian S Clin Obes; 2022 Apr; 12(2):e12501. PubMed ID: 34851557 [TBL] [Abstract][Full Text] [Related]
19. Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: The ATTICA cohort study. Kouvari M; Panagiotakos DB; Yannakoulia M; Georgousopoulou E; Critselis E; Chrysohoou C; Tousoulis D; Pitsavos C; Metabolism; 2019 Apr; 93():18-24. PubMed ID: 30639450 [TBL] [Abstract][Full Text] [Related]
20. Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese. Fingeret M; Marques-Vidal P; Vollenweider P Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):1036-1044. PubMed ID: 30139688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]